Takeda Hid Actos Adverse Effects, Regulators Said
According to a whistle-blower, a U.S. unit of Takeda Pharmaceutical Co. failed to accurately report hundreds of congestive heart failure cases associated with Actos, its diabetes drug.   Takeda did not properly classify “non-hospitalized
First Hearing for Actos Lawsuit
Actos LawsuitThe first court hearing regarding an Actos lawsuit has been scheduled by a federal judge in Louisiana. The claim is that Actos, a diabetes drug, is related to an increased risk of bladder